|  | Number (n = 189) | Low-HDLPO group (n = 32) | High-HDLPO group (n = 157) | P value |
---|---|---|---|---|---|
Sex | Male | 163 | 28 | 135 | 0.821a |
 | Female | 26 | 4 | 22 | |
Age | ≤50 | 69 | 13 | 56 | 0.596 |
 | >50 | 120 | 19 | 101 | |
Tumor number | Single | 151 | 26 | 125 | 0.833 |
 | Multiple | 38 | 6 | 32 | |
Tumor size | ≤5 | 120 | 18 | 102 | 0.351 |
 | >5 | 69 | 14 | 55 | |
Tumor encapsulation | None | 115 | 17 | 98 | 0.326 |
 | Complete | 74 | 15 | 59 | |
Satellite lesions | No | 166 | 27 | 139 | 0.524a |
 | Yes | 23 | 5 | 18 | |
Vascular invasion | No | 118 | 17 | 101 | 0.321 |
 | Yes | 71 | 15 | 56 | |
Tumor grade | I-II | 117 | 14 | 103 | 0.020 |
 | III-IV | 72 | 18 | 54 | |
Child-Pugh grade | A | 178 | 29 | 149 | 0.347a |
 | B | 11 | 3 | 8 | |
BCLC stage | 0Â +Â A | 138 | 24 | 114 | 0.781 |
 | B + C | 51 | 8 | 43 | |
AFP,μg/L | ≤400 | 139 | 21 | 118 | 0.265 |
 | >400 | 50 | 11 | 39 | |
ALT,μg/L | ≤40 | 178 | 32 | 146 | 0.124a |
 | >40 | 11 | 0 | 11 | |
GGT,IU/L | ≤54 | 110 | 17 | 93 | 0.559 |
 | >54 | 79 | 15 | 64 |  |
HbsAg | Negative | 23 | 1 | 22 | 0.100a |
 | Positive | 166 | 31 | 135 |  |
Recurrence | No | 100 | 11 | 89 | 0.032 |
 | Yes | 89 | 21 | 68 |  |